USP13 and ovarian cancer: Here, we developed a novel ovarian cancer GEMM, in which USP13 is overexpressed in ovarian surface epithelium (OSE) with the deletion of Trp53 and Pten by ovarian intrabursal administration of Cre recombinant adenovirus.